Abstract. mAbs were raised in mice against cultured human endothelial cells (EC) and screened by indirect immunofluorescence for their ability to stain intercellular contacts. One mAb denoted 7B4 was identified which, out of many cultured cell types, specifically decorated cultured human EC. The antigen recognized by mAb 7B4 is bound at the appositional surfaces of cultured EC only as they become confluent and is stably expressed at intercellular boundaries of confluent monolayers. EC recognition specificity was maintained when the antibody was assayed by immunohistochemistry in tissue sections of many normal and malignant tissues and in blood vessels of different size and type. The antigen recognized by 7B4 was enriched at EC intercellular boundaries similarly in vitro and in situ. In vitro, addition of mAb 7B4 to confluent EC increased permeation of macromolecules across monolayers even without any obvious changes of cell morphology. In addition, when EC permeability was increased by agents such as thrombin, elastase, and TNF/~/IFN, its distribution pattern at intercellular contact rims was severely altered, mAb 7B4 immunoprecipitated a major protein of 140 kD from metabolicaUy and surface-labeled cultured EC extracts which appeared to be an integral membrane glycoprotein. On the basis of its distribution in cultured cells and in tissues in situ, 7B4 antigen is distinct from other described EC proteins enriched at intercellular contacts. NH2-terminal sequencing of the antigen, immunopurified from human placenta, and sequencing of peptides from tryptic peptide maps revealed identity to the cDNA deduced sequence of a recently identified new member of the cadherin family (Suzuki, S., K.
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T HE structural and functional integrity of the endothelium is an essential requirement for its property of permselective barrier between the blood stream and the underlying tissues. The maintenance of a continuous endothelial cell (EC) t monolayer of tightly apposed cells is also central for preventing the vessel wall from platelet deposition and thrombus formation. Morphological studies in vitro and in vivo have shown the presence of tight junctions and gap junctions between adjacent EC. (Schneeberger and Lynch, 1984; Franke et al., 1988) .
In other cell types, cell-cell adhesion structures have been extensively studied and specific molecules of both the calcium dependent and independent cell adhesion mechanisms have been identified (Cunningham, 1990; Takeichi, 1990) but, in spite of the importance of cell-cell junctions in the maintenance of the endothelial functional properties, little is known about their structural and molecular organization.
Abbreviation used in this paper: EC, endothelial cell.
So far, a few integral membrane proteins have been described in the EC intercellular domain: PECAM-1 (Newman et al., 1990) , also called CD31 (Simmons et al., 1990; Miiller et al., 1989) or endo-CAM (Albelda et al., 1990) ; V-cadherin in bovine EC (Heimark et al., 1990 ) and the integrins ct~/3~ and o~2/3~ (Lampugnani et al., 1991) . Among these proteins, however, only V-cadherin was expressed exclusively in EC from bovine vessels. PECAM-1 was detected also in monocytes, polymorphonuclear cells, and platelets while ots/3t and o~2/3~ integrins have a widespread distribution. While the distribution and localization of the above proteins are well described, their role in the maintenance of EC intercellular contacts is not yet clear. Recently, PECAM-1 has been shown to mediate cell-cell adhesion of full-length PECAM-1 cDNA transfected cell (Albelda et al., 1991) .
To characterize the structures involved in EC intercellular junctions we raised mouse mAbs against cultured human umbilical vein EC. The resulting antibodies were screened by indirect immunofluorescence for their ability to stain intercellular boundaries of cultured human EC in monolayer.
Using this selective approach a mAb, denoted 7B4, was obtained that recognized an apparently novel antigen that was strictly distributed at intercellular EC boundaries not only in vitro but also in endothelia lining intact vessels within tissues.
Materials and Methods
Antibodies n'tAbs to cultured human EC from umbilical vein were raised in mice as extensively described by Pigott et al., 1991 . The isotype of both 7IM and 9GI 1 mAbs was IGgl. Purified antibodies were prepared from hybridoma supernatants by affinity chromatography on Prosep-A (Bioprocessing Ltd., Consett, England). Fab fragments were obtained by papain digestion (Pierce Chemical Co., Rockford, IL). mAb 9GI I recognizes the antigen PECAM-1/CD31 (Simmons et al., 1990) . As negative control either ascitic fluid containing the isotype matched mAb to CD2 lymphocyte antigen (OKTll, Ortho Diagnostic System Inc., Raritan, N.J.), which is not expressed by EC, or purified nonimmune mouse IgG (Calbiochem, La Jolla, CA) were used as indicated.
Rabbit anti-pan-cadherin serum (Geiger et al., 1990) was kindly provided by Dr. B. Geiger (Weizmann Institute, Israel) . Rabbit serum to N-or P-cadherin were a kind gift of Dr. Vestweber (MPI fOr Immunobiologie, Freiburg, Germany). These t~ antibodies were raised against bacterial fusion proteins containing, respectively, the human P-cadherin coding sequence from bp 759 to the natural stop codon and the mouse N-cadherin coding sequence from bp 1755 to 3 amino acids before the natural stop. mAb (Ec6C10) and rabbit polyclonal (6422) antibodies to V-cadherin were kindly provided by Dr. R. L. Heimark (ICOS Corporation, Bothell, WA),
Cells
Human EC were isolated from umbilical vein (Barbieri et al., 1981) by treatment with collagenase (0.1% from Clostridium histolyticum, Boehringer Mannheim, Germany) for 20 rain at 37~ Cells were cultured in medium 199 (Gibco Laboratories, Grand Island, NY) with 20% newborn calf serum (NCS; Gibco Laboratories). 100 #g/ml endothelial cell growth supplement (ECGS, prepared from bovine brain), 100 #g/ml heparin (from porcine intestinal mucosa; Sigma Chemical Co., St. Louis, MO, USA), 50 U/ml penicillin, 50 #g/ml streptomycin, 2.5 #g/rnl fungizone at 37~ Cells up to 10 in vitro passages were used.
Human femoral artery smooth muscle cells were a kind girl of Dr. G. Gabbiani (Department of Pathology, University of Geneva, Geneva, Switzerland) and cultured in DME (Gibco Laboratories) with 10% fetal calf serum (Gibco Laboratories). Human epidermal keratinocytes were kindly provided by Dr. M. De Luca (IST, Genova, Italy) and cultured as described by Marchisio et al. (1991) .
Human dermal fibroblasts were cultured in medium 199 with 20% NCS. Human blood polymorphonuclear cells (PMN) (Bazzoni et al., 1991) , platelets (Del Maschio et al., 1990) and monocytes (Colotta et al., I984) were isolated and washed as previously described in the related references.
Cell Treatments
Purified human c~-thrombin (1,665 U/mg) kindly donated by Dr. J. W. Fenton II (State University of New York at Albany) and human etastase (875 U/rag; from human sputum, ECP, Elastin Products, Owensville, MO) were used. They were added in serum free culture medium to confluent EC at the indicated doses and time intervals. Treatment with tumor necrosis factor-a (TNF, 100 U/ml human recombinant, Basf-Knoll, Germany) and 9 y-interferon (human recombinant ~/IFN, 200 U/ml, Hoffman La Roche, Nufley, NI) was started 24 h after cell seeding and continued for 72-96 h. When 7B4 either intact IGgs or Fab fragments were used in permeability experiments they were added in medium 199 with 5% NCS. 5 mM EGTA in serum-free culture medium was used to decrease extracellular Ca 2+ concentration (Heimark et al., 1990) in permeability and immunofluorescence experiments for the time intervals indicated. Neuraminidase (2 U/ml, from Clostridium perfringens, type X; Sigma Chemical Co.) was added to confluent 12Slodine surface-labeled EC (see below), in Ca 2+ and Mg 2+ PBS, pH 5.3, for 45 rain at 37"C before cell processing for immunoprecipiration as described below. Treatment of ~2~Iodine-labeled EC with trypsin (0.01%, Sigma "Pype III, 13,900 u/mg) was in Ca-Mg free Hanks buffer with either 1 rnM Ca 2+ or 1 mM EGTA for 20 min at 37~ Trypsin was stopped with soybean trypsin inhibitor (0.05 % Sigma, 1 nag inhibiting 1.6 nag trypsin with 10,000 U/rag) before cell processing for immunoprecipitation. Control incubations were in Hanks with 1 mM EGTA or 1 mM Ca 2+ and I mM Mg 2+. Phosphatidylinositol (PI)-specific phospholipaseC (PLC, 2 #g/ml Boehringer Mannheim) (Plong et at., 1991) in serum-free culture medium was given to 125Iodine-labeled EC for 20 min at 37~ before cell extraction for immunoprecipitation. Treatment with EDTA (50 #M) after 12Slodine surface labeling of conflnent EC was for 15 min at 37~ (M~ller et al., 1989) . Cells were then processed for immtmoprecipitation as described below.
Cell Labeling and Extraction
[35S]Methionine Metabolic Labeling. EC which had grown to conflnency, unless otherwise indicated, on gelatin-coated 10-cm: well plates were washed twice with methionine-free RPMI (Gibeo Laboratories) and cultured overnight in methionine-free RPMI with 20% NCS ECGS, and heparin (see above) comaining 60 #Cilml [3~S]methionine (Amersham International, Buckingham, UK). Cell layers were then washed three times with serum-free medium 199 and extracted with 280 ttl of 10 mM NaCI, 10 mM Tris-HCl, 0.5 % sodium deoxycholate, 1% Tween 40, 1 mM PMSE 20 U/ml aprotinin, pH 7.4. Cell extracts were centrifuged for 5 rain in an Eppendorf centrifuge at 13,000 rpm. The supernatant was stored at -20~ for immunoprecipitation analysis.
~25Iodine-Surface Labeling. EC which had grown to confluency, unless otherwise indicated, on gelatin-coated 10 cm 2 well plates were washed three times with Ca2+-Mg 2+ Dulbecco's PBS. Cells were labeled using the glucose oxidase-laetoperoxidase method (Labien et al., 1982) . Briefly, one well was incubated with 500 tzl Ca2+-Mg 2+ PBS containing 20 #g/ml lactoperoxidase, 0.25 U/ml glucose oxidase, 200 tzCi/ml 125Iodine (NEN, DuPont, Dreieichenhain, Germany). 2.5 mM glucose for 5 min on ice. Glucose, 2.5 mM, was added again and the reaction continued for 5 more min. The reaction was stopped with 3 ml of medium 199 containing 0.02 % azide. The cell layer was washed three more times with medium 199 containing 0.02 % azide and extracted as described above. In a few experiments, cell extraction was with 150 mM NaC1, 10 mM Tris HCI, 1 mM PMSF, 20 U/ml aprotinin, and either 1% Triton X-100 (TX-100) or 1% Triton X-II4 (TX-114). TX-114 buffer and detergent phase were separated as described by Bordier (1981) .
lmmunoprecipitation
Protein G-Sepbarose (recombinant; Pharmacia, Uppsala, Sweden) was washed three times with TBS (150 mM NaC1, 10 mM Tris-HCl, pH 7.4). For each sample, the resin pelleted from 500 t~l of a 10% suspension was used. Coupling with the antibodies (either 500 #1 undiluted hybridoma conditioned medium for 7134 and 9GII or 25/~g/ml of purified IgGs or 300 #1 TBS containing a 1:200 dilution of the nonrelevant IgG isotype matched CD2 ascitic fluid) was for 60 rain at room temperature under continuous mixing. The resin was then washed with TBS containing 1% Tween 40, 1 mM PMSF, 20 U/ml aprotinin, and 1 mM CaCI2, MgC12, and MnCI2, respectively (immunoprecipitation buffer). Incubation of cell extracts with protein G-Sepharose was in a total volume of 300-500 #I immunoprecipitation buffer for 1 h at room temperature under continuous mixing. The presence of divalent cations during this phase was mandatory to effective immunoprecipitation with mAb 7B4. In some experiments, as indicated, samples were precleared by incubating them for 1 h with uncoupled protein G-Sepharose. The supernatant was collected and used in immunoprecipitation. The resin was washed three times with immunoprecipitation buffer (1 ml a time). Sample buffer 2• (50/~1 of 20% Tris-HCl 0.5 M, pH 6.8, 5% SDS, 20% glycerol, 0.25 mg/ml bromophenol in water; when indicated 5 % 2-mercaptoethanol was added as a reducing agent) was added to the resin pellet which was boiled for 3 min. Supernatant was analyzed by electrophoresis on a 7.5% polyacrylamide gel in the presence of SDS. In each separation, 14C-molecular weight standard proteins (Amersham International) were run in parallel to the samples. Dryed gels were exposed for autoradiography on X-AR film (Eastman Kodak Co., Rochester, NY) at -70"C. Gels with [3SS]methionine labeled samples were equilibrated with EN3HANCE (NEN) before drying and exposure. Quantification of the band was made after digital image analysis of the film (RAS 3000 Loats System; Amersham International).
Sepharose (Pharmacia LKB) in TBS with 1 mM CaC12, 1 mM MgC12, and 1 mM MnC12 (binding buffer) either in the absence or in the presence of 0.5 M methyl c~-o marmopyranoside (Sigma Chemical Co.) for 1 h at room temperature. The unbound fraction (supernatant) was stored. The resin was washed with binding buffer and bound material (eluant) eluted, incubating the resin with the competing sugar methyl-cc-D mannopyranoside (0.5 M) for 1 h at room temperature. Both the supernatant and the eluant fractions were subjected to immunoprecipitation. Binding to wheat germ agglutinin (WGA) agarose (Pharmacia) was identical to the binding to Con A except that N-acetyl-D-glucosamine (0.5 M; Sigma Chemical Co.) was used as competing sugar.
Immunoblotting
After separation by SDS-electrophoresis, samples were electrotransferred onto nitrocellulose (Bio-Rad Laboratories, Richmond, CA) blocked with 3 % BSA (fatty acid free type; Sigma Chemical Co.) in PBS and incubated overnight with a 1:100 dilution of either a rabbit anti-pan-cadherin serum or rabbit serum to N-or P-cadherin (see previous "Antibodies" section). The immunoreactive bands were revealed by 125Iodine-labeled protein A (Amersham International) followed by autoradiography.
Immunofluorescence
Cells to be examined by immunofluorescence microscopy were grown on glass coverslips. Glass coverslips (13-ram diameter) were coated overnight at 4~ with either 1.5% gelatin (Difco) or 7 #g/ml fibronectin purified from human plasma (Engvall and Ruoslahti, 1977) or 7 #g/ml vitronectin purified from human serum (Yatohgo et al., 1988) , then rinsed with serum-free medium 199 before seeding 3.5 x 104 cells/coverslip in 0.4 ml culture medium. Cells were grown to confluency for 72 h, unless otherwise specified. Coverslip-attached cells were then fixed with paraformaldehyde and processed for immunofluorescence microscopy as previously described in detail (Lampugnani et al., 1991) . Briefly, the primary antibody was layered on fixed and permeabilized cells and incubated in a humid chamber for 30 min. After rinsing in 0.1% BSA in TBS, coverslips were incubated in the appropriate rhodamine-tagged second antibody (Dakopatts, Glostrup, Denmark) for 30 min at 37~ in the presence of 0.2 #g/ml of fluoresceinlabeled phalloidin (F-PHD; Sigma Chemical Co.). Coverslips were then mounted in Mowiol 4-88 (Hoechst, Frankfurt, Germany).
Observations were carried out in a Zeiss Axiophot photomicroscope equipped for epifluorescence. Fluorescence images were recorded on Kodak T-Max 400 films exposed at 1000 ISO and developed in Kodak T-Max developer for 10 rain at 20~
Immunohistochemistry
Fragments of human normal kidney (2), heart (2), lung (3), thymus (3), lymph nodes (5), thyroid (2), parathyroid (1), salivary gland (1), stomach (2), small and large intestine (2), testis (1), bone marrow (1), placenta (1) lung carcinoma (3), and intestinal carcinoma (2) were obtained at surgery or at autopsy. Tissue fragments were embedded in OCT compound (Ames Division, Miles Laboratories, Elkhart, IN), snap frozen in liquid nitrogen, and stored at -80~ until sectioning. Other fragments were formalin-fixed and paraffin-embedded for conventional histology. Cryostat sections were fixed in acetone for 10 min at room temperature and were immunostained with anti-PECAM-1/CD31 (mAb 9Gll) or mAb 7B4 using avidin-biotinperoxidase complex technique. Sections were preincubated with normal horse serum to prevent nonspecific binding, and then incubated with an optimal dilution of the primary antibody (1/10) for 30 rain. The slides were sequentially incubated with biotin-conjugated horse anti-mouse Ig antibodies followed by avidin-biotin-peroxidase complex (PR 4002; Vector Laboratories, Burlingame, CA). Each incubation step lasted 30 min with 5-rain TBS washes between each step. The sections were finally incubated with 0.03% H20~ and 0.06% 3,3' DAB (Sigma Chemical Co.) for 3-5 min. Slides were then washed for 5 min in running tap water, counterstained with hematoxylin for 5 rain, and mounted in Canada balsam. Endogenous peroxidase was generally visualized only in eosinophils.
Measure of EC Barrier Properties
The Transwell TM cell culture chambers (polycarbonate filters, 0.4 #m pore size, Costar, Cambridge, MA) were used as described by Lampugnani et al. (1991) . The polycarbonate filters were coated with 10 /zg/ml human fibronectin for 1 h at room temperature, rinsed with serum-free medium before seeding 2 x 104 cells in 100/zl culture medium in the upper compartment. 600 #l of culture medium filled the lower compartment. Culture was continued for 5 d with daily refeeding. Before the experiment, the culture medium of both the upper and lower compartments was replaced with medium 199 either serum free or with 5% NCS as indicated in the "Cell treatments" paragraph. HRP (0.126/zM; HRP, VI-A type, 44,000 mol wt, 1,280 U/mg; Sigma Chemical Co.) was added to the upper compartment. After 1 h at 37~ the medium in the lower compartment was collected and kept on ice until the enzymatic activity of HRP was assayed. To assay HRP enzymatic activity (Ortiz de Montellano et al., 1988) , 60 #1 of the culture medium, collected from the lower compartment, was added to 860 #1 of a reaction buffer (50 mM NaH2PO4 with 5 mM guaiacol) and the reaction was started by adding 100 #1 H202 (0.6 mM in H20, freshly made solution). The reaction was allowed to proceed for 25 min at room temperature before measuring the adsorbance at 470 ran.
A~inity Chromatography
Human placentae were minced, lysed with 0.005 % digitonin (Calbiochem, San Diego, CA) in TBS with 1 mM Ca 2+, 1 mM Mg 2+ and 1 mM Mn 2+ (Ca2+/Mg2+/Mn 2+ TBS), 1 mM PMSF, and 20 U/mi aprotinin for 15 min at 4~ followed by 10 min centrifugation at 5,000 g at 4~ Pellets were extracted with 1% Tx-100 (Bio-Rad Laboratories) in Ca2+/Mg2+/Mn 2+ TBS, 1 mM PMSF, and 20 U/ml aprotinin for 1 h at 4~ The extract was centrifuged for 30 rain at I0,000 g at 4~ The supernatant was stored at -70~ before processing. mAb 7B4 purified IgGs were covalently coupled to CNBr-Sepharose (Pharmacia), according to the manufacturer's instructions. Placenta extract was passed through a 7B4-CNBr-Sepharose column. The column was washed with Ca2+/Mg2+/Mn 2+ TBS and the antigen eluted with 0.1 M acetic acid, pH 2.5. Samples were stored at -70~ before further processing.
Protein Sequencing
Proteins and peptides were sequenced on a Sequenator (Model 477A; Applied Biosystems) using chemicals and protocols supplied by the manufacturer. For direct NH2-terminal sequencing, samples of 100-200/zl were dried down on Protein support filters (Porton Instruments) and placed in the sequenator reaction cartridge.
For sequencing of proteins after SDS-PAGE, gels were subjected to overnight preelectrophoresis in 0.375 M Tris-HCl, pH 8.8, 0.1% SDS, 20 mM mercaptopropionic acid with a current of 5 mA/gel. Samples were boiled in sample buffer and subjected to electrophoresis in 25 mM Tris, 0.2 M glycine, 0.1% SDS, pH 8.3. After SDS-PAGE the proteins were electroblotted onto polyvinyl difluoride membranes using 25 mM Tris, 0.2 M glycine, pH 8.3 as transfer buffer. The membranes were stained with Coomassie R 250 in 40% MeOH and destained in 40% MeOH. After extensive washing with water individual bands were cut out and subjected to sequencing.
Peptide Mapping
Samples were dissolved in 100 ~1 of 0.1 M phosphate buffer, pH 7.5, containing 20% MeOH and TPCK-Trypsin (Worthington) was added (enzyme/substrate ratio 1:100 [wt/wt]). After incubation overnight at 37~ a second aliquot of trypsin was added and digestion was continued for 2 h at 37~ The reaction was terminated by addition of trifluoroacetic acid (TFA) to 1% (vol/vol) and samples were chromatographed on a 0.2 cmx 20 cm RP-C18 column (5/zm particles) using a model 130 A HPLC system (Applied Biosystems) and linear gradient from 0.1% TFA to 70% CH3CN, 0.085% TFA over 50 min (flow: 275/~l/min). Individual peaks were collected and subjected to automated sequence analysis as described above.
Results

Localization of 7B4 Antigen in Cultured Human Endothelial Cells
Cultured EC monolayers were examined by immunofluorescence microscopy. As reported in Fig. 1 partment that may be identified with the Golgi area (see also Fig. 1, e and g ). When confluent monolayers of EC were decorated with a PECAM-1/CD31 mAb a different pattern of staining was observed (Fig. 1 b) . The fluorescence signal along cell margins was more discontinuous and in many areas more diffuse than with mAb 7B4.
The distribution of mAb 7B4 antigen at cell margins was essentially identical when EC were seeded on different substrata such as gelatin, fibronectin, or vitronectin. Further, staining pattern and intensity did not change up to 10 cell passages (not shown).
The presence of 7B4 antigen and, for comparison, that of PECAM-1/CD31 in other cell types including circulating cells (such as platelets, monocytes and granulocytes), other components of the vessel wall (such as fibroblasts and smooth muscle cells), or keratinocytes was examined by indirect immunofluorescence, mAb 7B4 recognized only EC while it did not bind to any other tested cell type (Table I and, e.g., Fig. 1, c and d) . In contrast, as expected (Newman et al., 1990) , PECAM-1 was detected in monocytes, polymorphonuclear cells and platelets (Table I ). The reactivity of 7B4 was restricted to human EC; bovine EC from both large vessels and capillaries were negative (not shown). The enrichment of 7B4 at cell borders requires the establishment of intercellular contacts. In nonconfluent cultured EC examined by indirect immunofluorescence the antigen was detected only at contacting cell borders and never along free cell edges (Fig. 1, e and f ) . In nonconfluent EC the level of the antigen exposed at the cell surface was comparable to that of confluent cells. Indeed, mAb 7B4 immunoprecipi- tated comparable amounts of ~25Iodine-labeled protein from the same number of either confluent or nonconfluent EC (not shown). The maintenance of 7B4 antigen at the cell-cell contacts depends on the presence of Ca 2 § EGTA (5 mM for 20 min) induced the disappearance of the antigen from the cell boundaries even in the areas of apparent residual intercellular contacts (Fig. 1, g and h) . This effect was accompanied by increased permeability of the EC monolayer (see Table  HI ). The amount of 125Iodine-labeled protein immunoprecipitated by mAb 7B4 was comparable in EGTA-treated and in control cells (see also Fig. 4 ), thus indicating that the treatment induces a redistribution of the protein on the cell membrane but not its disappearance.
Expression of 7B4 Antigen In Situ
Expression of 7B4 antigen in situ was studied in a series of tissues, as listed in Table II . For comparison, the immunolocalization of PECAM-1/CD31 was also examined. The 7B4 antigen and PECAM-1 showed a different cellular distribution in tissue sections. Immunoreactivity to 7B4 was restricted to the vascular endothelial layer of the vessels in all the tissues examined, which comprised both normal and malignant tissues. The molecule was constitutively expressed in the endothelium of muscular arteries, arterioles, capillaries, venules, and veins and was mostly present at EC boundaries as shown in Fig. 2 (a and c) . No significant staining was observed on the apical or basal aspect of EC membrane or in the cytoplasm. Cardiac and skeletal muscle, vascular smooth muscle, macrophages, fibroblasts, and any tested epithelial type did not contain detectable levels of this antigen. The immunostaining for PECAM-1/CD31 was different from that of 7B4 both in terms of tissue specificity and cellular localization. In fact, PECAM-1/CD31 was present also in nonendothelial cells, including platelets, megakaryocytes, and macrophages. In addition, the staining for PECAM-1/CD31 in EC lined intercellular contact rims and was also diffuse in the cytoplasm (Fig. 2 b) . Interestingly, the pattern of cellular localization of 7B4 and PECAM-1/CD31 in tissue sections was similar to that observed in cultured EC (compare Fig. 1, a and b) .
Biochemical Characterization of 7B4 Antigen
To identify the antigen recognized by mAb 7B4, extracts from [35S]methionine-labeled EC were immunoprecipitated with the mAb. As shown in Fig. 3 (A) , mAb 7B4 precipitated a major protein band of ~140 kD apparent molecular mass. As a control an isotype matched mAb to CD2 lymphocyte Cryostat sections of skin, kidney, heart, lung, thymus, lymph node, thyroid, parathyroid, salivary gland, stomach, ileum, colon, testis, placenta, bone marrow, lung squamous carcinoma, and colon adenocarcinoma were immunostained with mAb 7B4 and mAb 9Gll to PECAM-1 using avidin-biotinperoxidase method. * The antigen was constitutively expressed by EC in all tissues examined. The reactivity was present in muscular arteries, arterioles, capillaries, venules, and veins. * The reactivity was expressed by macrophages lining lymph node sinuses. These cells represent a peculiar subset of macrophages sharing many features with EC.
antigen, which is not expressed by EC, was used in all the immunoprecipitation experiments (Fig. 3) . These data indicate that 7B4 recognizes a protein synthesized by EC. mAb 7B4 immunoprecipitated a major band of 140 kD also from 125Iodine-surface labeled EC (Fig. 3 B) , indicating that the antigen is externally exposed. After reduction with 2-mercaptoethanol, the apparent molecular mass increased slightly to 145 kD (Fig. 3 B) , suggesting that intrachain disulfide bonds are present in the molecule.
Neuraminidase treatment (2 U/ml for 45 min) resulted in a decrease to 135 kD of the apparent molecular mass (Fig.  3 C) , suggesting sialylation of the protein. Furthermore, the protein recognized by 7B4 bound to Con A, but not to WGA (Fig. 3 D) suggesting that it is a glycoprotein with mannosecontaining oligosaccharide moieties.
EDTA (50/~M for 15 min at 37~ Miiller et al., 1989) did not strip 7B4 antigen from EC surface (data not shown), thus, indicating that it is an integral membrane protein. In apparent contrast, when 125Iodine-labeled EC were extracted with TX-114 detergent the 7B4 antigen was mostly immunoprecipitated from the buffer phase (Fig. 4 A) . This unexpected distribution has been reported for other integral membrane proteins (Volk and Geiger, 1986 and references therein).
7B4 was sensitive to trypsin (0.01% for 20 rain) both in the absence and presence of Ca 2+ (Fig. 4 A) .
PI-specific PLC did not detach 7B4 from the cell surface (Fig. 4 A) . This makes unlikely a connection through PIcontaining lipids as reported for other membrane proteins (Ferguson and Williams, 1988) . 100-kD band(s) appeared constantly in the immunoprecipitate from 12qodine surface-labeled EC at variable intensity and was found occasionally in [3sS]methionine-labeled EC. Surface iodination requires longer cell manipulation before extraction than [35S]methionine metabolic labeling (see Materials and Methods). In preliminary experiments, we found that the intensity of this band increased in parallel to a decrease of the 140-kD band when the cell extract was repeatedly frozen and thawed. We then suggest that the 100-kD band represents a degradation product of the higher 140-kD band. An unspecific band of •180 kD appeared in the immunoprecipitates from 12qodine-surface labeled EC of both CD2 and 7B4. This protein had an immunoglobulinlike behaviour as it linked to protein G-Sepharose in the absence of CD2 or 7B4 (not shown) and its molecular mass decreased to ,~55 kD upon reduction (Fig. 3 B) . Immunoprecipitates of cell extracts precleared on protein G were depleted of this unspecific band (Fig. 4, A and B) . It is not a metabolic product of the cells, as it never appeared in immunoprecipitates from [3~S]methionine-labeled EC. Overall, this strongly suggests that it represents serum derived IgG absorbed to EC from the culture medium.
Comparison of 7B4 to Other EC Adhesion Proteins
Intercellular location and size suggest that 7B4 antigen could be similar to other molecules previously found at intercellular EC contacts. By immunoprecipitafion analysis, PECAM-1/CD31 migrates at a lower position than 7B4 antigen (Fig.  4 B) . Furthermore, while 7B4 is sensitive to trypsin treatment (Fig. 4 A) , PECAM-1/CD31 was detached in trypsinized cells (not shown). These data and the differences in cell recognition specificity (Tables I and II) indicate that 7B4 is a protein distinct from PECAM-1/CD31. Furthermore, transfected COS cells expressing a full-length PECAM-1 molecule are not recognized by mAb 7B4 (R. Pigott, unpublished results) .
EC reportedly express mRNA for membrane proteins of the intercellular contacts belonging to the cadherin family: N and P (Liaw et al., 1990) . Cadherins have a molecular weight in the range of that of 7B4 antigen. We therefore tested whether the 7B4 antigen could be recognized by cadherin antibodies. A polyclonal antibody directed to the COOH-terrnlna124 amino acid domain of cadherins (Geiger et al., 1990 ) was used. The conserved nature of this domain allows this antibody to react with all known cadherins. This antibody detected a band at the expected 140 kD apparent molecular mass in the total EC extracts (Fig. 5 A) , thus confirming the presence of cadherins in human EC. It also recognized a band of slightly lower molecular mass in the immunoprecipitate of mAb 7B4. As expected, no reactivity was found in the immunoprecipitate of anti-PECAMA (Fig.  5 A) . When polyclonal antibodies to N-and P-cadherins could not be immunoprecipitated from the eluant of WGA-agarose obtained washing the resin with the competing sugar n-aeetylglucosamine. 7B4 antigen was present, as expected, in the unbound fraction supernatant. The migration of molecular weight standards run in parallel is shown on the right of each panel.
were used in the same kind of experiments they recognized a protein band of ~140 kD in the total cell extract (Fig. 5  B) . The band recognized by anti-P-cadherin was much fainter than that recognized by anti-N-cadherin, in apparent agreement with Liaw et al. (1990) . None of the two antibodies detected any specific band in the immunoprecipitate of mAb 7B4 (Fig. 5 B) thus indicating that 7B4 antigen does not correspond to N-or P-cadherins. The high MW bands detected in both the 7B4 and PECAM-1 antibodies immunoprecipitates are the IgG recognized by iodinated protein A (Fig. 5, A and B) . Both a monoclonal and a polyclonal antibody to bovine endothelial cell V-cadherin (Heimark et al., 1990) did not recognize any specific band in cultured human umbilical vein EC, possibly indicating a lack of crossreactivity.
Identification of 7134 Antigen as a Novel Cadherin by Amino Acid Sequencing
Preparations of 7B4 antigen purified by immunoaflinity columns from placenta tissue were subjected to automated NH2-terminal microsequencing yielding information up to residue 17 (Fig. 6) . The 7B4 antigen NH2-terminal sequence showed identity with the cDNA deduced NH2-terminal sequence of a new member of the cadherin family recently characterized at the cDNA level and denoted cadherin-5 (Suzuki et al., 1991) (Fig. 6) . Tryptic mapping of the protein and sequencing of the resulting peptides indicated identity also in some internal sequences (Fig. 6) .
Effect of mAb 7B4 on Endothelial Cell Barrier Function
The intercellular location of 7B4 suggests that it can play a role in the functional organization of endothelial cell to cell junctions. When mAb 7B4 either in the form of intact IgG (up to 400/~g/rnl) or Fab fragments (up to 400 #g/ml) were added to EC monolayers up to 12 h, they had no apparent effect on cell morphology as examined by phase-contrast microscopy and immunofluorescence by actin staining (not shown). To increase our sensitivity, we then used a permeability assay, which had been previously found to show varia- tions of the barrier function of EC even in the absence of overt morphological alterations (Lampugnani et al., 1991) . When Fab fragments were added to EC grown on Transwell filters a dose-response increase in the permeability of the EC monolayer was observed (Fig. 7) . This increase was apparent at "0100 gg/ml mAb and at a minimal time of incubation of 2 h reaching a plateau between 4 and 6 h (not shown). Comparable results were also obtained with intact IgGs.
7B4 Antigen Organization in Endothelial Cells Treated with Agents That Alter Monolayer Integrity
Several molecules have been reported to alter morphology and intercellular contacts of EC. As reported in Table HI , treatment of EC with TNF and 7IFN, with thrombin or elastase significantly increased monolayer permeability in TransweU experiments.
We checked first by indirect immunofluorescence the effect of these treatments on the distribution of 7B4 antigen. Thrombin added to the cells (5 U/ml for 30 min) induced retraction accompanied by small areas of detachment at intercellular boundaries (see actin, Fig. 8 c) . 7B4 antigen dis- appeared from areas of cell retraction and the staining was restricted to residual cell contacts (Fig. 8 d, 
arrows).
Changes in 7134 antigen distribution was even more dramatic after elastase treatment of the cells (0.8 #M for 30 min) (Fig.  8f) . Cell retraction was observed after treatment (see actin, Fig. 8 e) , yet 7B4 antigen did not show any discrete distribution even at residual intercellular contacts, but was diffusely distributed on EC membrane. Interestingly, the effect of thrombin on cell retraction and 7B4 localization was fully reversible in ~ol h, even in the continuous presence of the stimulus. In contrast the effect of elastase was not reversible up to 3-4 h (not shown).
When EC were incubated with 7IFN and TNF (200 U/ml and 100 U/ml for 72 H) they acquired elongated morphology with relaxed intercellular contacts (Fig. 8 g) as described (Stolpen et al., 1986) . 7B4 assumed a peculiar, punctate distribution all over the cell body and could be found at cell to cell contacts only in a few areas (Fig. 8 h) .
We then investigated whether the morphological effects observed after EC treatment with thrombin, elastase or 3,IFN and TNF were paralleled by quantitative or qualitative modification of 7B4 antigen. As reported in Fig. 9 , the amount of 125Iodine-labeled antigen precipitable by mAb 7B4 was unmodified after 7IFN and TNF (Fig. 9 B and et al., 1991) . Sure residues are shown by capital letters and < 100% sure residues are indicated by lower letters. A "-" indicates that no residue was identified. The predicted proteolytic processing site of the precursor is indicated with an arrow. (N) Potential asparagine glycosylation sites. The putative transmembrane region is underlined.
tiaUy reduced after thrombin or elastase (30 and 40%, respectively; Fig. 9 A) .
Discussion
In this paper we describe several biological and biochemical characteristics of a novel, endothelial-specific cadherin. This protein was identified adopting the indirect approach of developing mouse mAbs to human EC and selecting one mAb, denoted 7B4, on the basis of its ability to stain intercellular boundaries in indirect immunofluorescence. mAb 7134 stains EC both in vitro and in situ. In tissue sections it stains only the endothelium of blood vessels of different size and origin in a variety of normal and malignant tis- on the permeation through EC monolayer of HRE EC were grown to confluency on Traswell filters. The EC monolayer was incubated for 6 h with the indicated doses of 7B4 Fab fragments and the ~oo 2oo 400 7~ ~,9:m) passage of HRP through the endothelial layer was measured during the last hour. The ordinate is the percentage increase over control of the OD at 470 nm. Control EC were treated with Fab (400 #g/ml) from nonimmune mouse IgG. Control value was 235 • 30 x 10 -30D at 470 nm. The mean value of triplicate determinations + SD in a representative experiment out of six performed are shown. sues and it does not recognize circulating blood cells, such as monocytes, polymorphonuclear cells, and platelets. Furthermore, mAb 7B4 does not react with any other tested cultured cell types (including human fibroblasts, smooth muscle cells and keratinocytes).
The issue that 7B4 antigen is a component of intercellular junctions is supported by its exclusive immunocytochemical localization in situ and in vitro. The fluorescence pattern observed in cultured EC closely resembles that observed by immunohistochemistry in different vessels in situ. In either condition, mAb 7B4 identifies a fine, continuous line along the rim of intercellular boundaries. In cultured EC, peripheral staining is observed exclusively at contact rims, while contact-free segments of the cell membrane are negative in subconfluent cultures. A constant feature of 7134 antigen is its abundant intracellular storage in vitro, presumably in a Golgi-like vesicular compartment. Data of 7B4 distribution are consistent with a role of 7B4 antigen in regulating EC cell-cell adhesion structures. Additional functional data supports this hypothesis. First, mAb 7B4 increases the permeability of EC cultured or Transwell filters by ,-o40% over the control value. Second, comparing confluent vs subconfluent cells, the antigen is localized at cell boundaries only where cells come in touch. Third, 7B4 topography is markedly modified by treatments such as -yIFN and TNF, thrombin and elastase that increase EC permeability.
Interestingly, in cells treated with thrombin and elastase, 7B4 disappearance at cell boundaries is accompanied by a moderate decrease in the amount of antigen expressed by the cells. In contrast, in sparse cells or in ceils treated with 7IFN and TNF the changes in 7B4 distribution do not correspond to detectable changes in 7B4 qualitative or quantitative expression. This suggests that 7]34 organization in intercellular junctions could be regulated not only by direct digestion/de novo exposure of the antigen but also by antigen disassembling and relocation within the cell membrane.
The 7B4 antigen has been characterized for several biochemical properties. First, by lactoperoxidase-catalyzed iodination it appears to be externally exposed and EDTA treatment supports its firm association with the phospholipid bilayer (Mfiller et al., 1989) . Further, it is produced by EC since it can be immtmoprecipitated from metabolically labeled cell extracts. A second prominent biochemical property is its content of mannose and sialic acid oligosaccharide moieties witnessing its glycoprotein nature. The apparent molecular mass of the 7B4 antigen is 140 kD. An additional band or group of bands of "o100 kD is occasionally precipitated from metabolically labeled and constantly precipitated from surface-labeled EC extracts. Since its intensity increases in parallel to a decrease of the 140-kD band in several experimental tests, including repeated freezing and thawing cycles, it is likely that it represents a degradation product of the higher MW protein.
Many characteristics of 7B4 are in common with some members of the cadherin family. These include (a) sensitivity to trypsin digestion (Albelda, 1990) ; (b) partition in TX-114 buffer phase (Volk and Geiger, 1986) ; (c) binding to ConA (Damsky et al., 1983; Volk and Geiger, 1986) ; (d) requirement of Ca 2+ for the localization of the antigen at the cell contacts (Volk and Geiger, 1986; Vestweber et al., 1985; Takeichi, 1990) . In addition, 7B4 antigen is recognized by a polyclonal antibody directed to the conserved COOHterminal cytoplasmic domain of all known cadherins.
The NH2-terminal sequence data and sequence data from tryptic peptide mapping confirmed that 7B4 is indeed a member of the cadherin family. The sequences essentially showed identity with the cDNA deduced sequence of a new member of the cadherin family recently characterized and denoted as cadherin-5 (Suzuki et al., 1991) . This molecule was identified in human placenta cDNA by the aid of polymerase chain reaction using degenerated primers corresponding to highly conserved amino acid sequences from the cadherin cytoplasmic domain. The entire putative coding sequence of cadherin-5 has been reported (Suzuki et al., 1991) and exhibits significant homology with those of the previously described cadherin sequences and the overall molecular structure is essentially the same as that of the other cadherins. Data reported here confirm the existence of a cadherin-5 protein and characterize its biochemical and biological behaviour. The specific localization of this protein in endothelial cells distinguishes this cadherin from the other members of the family that present a quite widespread distribution. This molecule appears to be a candidate not only as a specific marker for endothelial cell junctions but also as a potential regulator of endothelial continuity required for the maintenance of permeability control and the antithrombotic properties of the endothelium.
